The frequency of penicillin resistant strains of gonococci and the danger that penicillin may mask concomitant syphilitic infection, together with the aural and renal hazards of streptomycin, encourage the trial of other antibiotics in gonorrhoea. Having already studied the use of oral trisulphazineaureomycin in the treatment of gonorrhoea (Piguet and Foerster, 1954) we have recently used an injectable preparation which offered a safer method of treating the type of patient seen in our clinic, many of whom are North Africans and foreigners who have difficulty in understanding and following therapeutic directions. This was our principal reason for welcoming a trial of intramuscular Kanamycin sulphate for gonorrhoea. Moreover, this antibiotic did not seem to entail the same risk of serious or even fatal reactions as sometimes occurs with penicillin, nor did it have any effect on intercurrent treponemal infection. However, as with streptomycin, there is a slight risk of renal or cochleo-vestibular complications, but these are negligible with the very short courses of treatment usually given in cases of gonorrhoea. As a further precaution, all patients who had had previous renal or aural symptoms were excluded from the trial.
The treatment of gonorrhoea with Kanamycin sulphate has already been reported, mostly from abroad. Ichikawa (1958) treated sixteen men and two women, giving the men 1 to 2 g. daily to a total of 1 to 6 g., and the women up to 10 g. In fifteen acute cases, he had thirteen successes and two failures.
The longest study so far undertaken is that of Marmell and Prigot (1959, 1960) , who treated 124 cases of gonorrhoea with Kanamycin sulphate using four different treatment schedules (Table I ). That one failure was seen amongst those treated with a maximum dose of 3 g., while there were no failures in those treated with less than 2 g., appears to be fortuitous and merits no special conclusion. With a total dose of 2 g. Kanamycin sulphate in 2 days, the proportion of failures in male gonorrhoea is less than 10 per cent., the true rate being probably about 5 per cent. 244 Sixteen patients received 1 g. on three successive days; one failure was observed which required treatment with streptomycin.
25 patients received 1 g. on two successive days; no true failure was observed.
Seven patients received a single injection of 1 g.; there were only three immediate successes but retreatment with one or two additional injections of 1 g. produced a cure in three of the four failures.
A single injection of 1 g., although often producing complete dryness of the urethra 24 hours later, does not appear to give sufficient security, because 60 per cent. of the early failures occurred in cases in which the dosage was limited to a single injection. Although relapse of the gonococcal urethritis in such cases is frequent, it responds to further treatment with Kanamycin.
Three cases of gonococcal leucorrhoea in women were treated with success.
No allergic manifestations were observed. 
